Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Hyperthyroidism" and "Society guideline links: Hypothyroidism" and "Society guideline links: Medullary thyroid cancer".)
Canada
●Choosing Wisely Canada: Don't routinely order a thyroid ultrasound in patients with abnormal thyroid function tests unless there is a palpable abnormality of the thyroid gland (updated 2020)
United States
●American Thyroid Association (ATA): Guidelines for management of patients with anaplastic thyroid cancer (2021)
●American Association of Endocrine Surgeons (AAES): Guidelines for the definitive surgical management of thyroid disease in adults (2020)
●ATA, the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and the European Thyroid Association (ETA): A joint statement on controversies, consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer (2019)
●American College of Radiology (ACR): ACR Appropriateness Criteria thyroid disease (2018)
●ACR: Thyroid Imaging Reporting and Data System (TI-RADS) – A user's guide (2018)
●Children's Oncology Group (COG): Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers (2018)
●Choosing Wisely: Don't routinely order a thyroid ultrasound in patients with abnormal thyroid function tests if there is no palpable abnormality of the thyroid gland (2013, updated 2018)
●US Preventive Services Task Force (USPSTF): Final recommendation statement – Thyroid cancer: Screening (2017)
●American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), and Associazione Medici Endocrinologi (AME): Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules, update (2016)
●American Head and Neck Society (AHNS): A statement on external-beam radiotherapy for differentiated thyroid cancer locoregional control (2016)
●ATA: Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis (2016)
●ATA: Statement on remote-access thyroid surgery (2016)
●ATA: 2015 Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer (published 2016)
●ACR: Thyroid ultrasound reporting lexicon – White paper (2015)
●ATA: Management guidelines for children with thyroid nodules and differentiated thyroid cancer (2015)
●ATA: Statement on surgical application of molecular profiling for thyroid nodules – Current impact on perioperative decision making (2015)
●Choosing Wisely: Don't order multiple tests in the initial evaluation of a patient with suspected thyroid disease. Order thyroid-stimulating hormone (TSH), and if abnormal, follow up with additional evaluation or treatment depending on the findings (2015)
●Choosing Wisely: Don't use nuclear medicine thyroid scans to evaluate thyroid nodules in patients with normal thyroid gland function (2013)
●ATA: Guidelines for management of patients with anaplastic thyroid cancer (2012)
●ATA: Practice recommendations on radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I (2011)
Europe
●European Society for Medical Oncology (ESMO): Clinical practice guideline on the use of systemic therapy in advanced thyroid cancer, update (2022)
•ESMO: Thyroid cancer – Clinical practice guidelines for diagnosis, treatment and follow-up (2019)
●European Thyroid Association (ETA): Clinical practice guideline for the use of image-guided ablation in benign thyroid nodules (2020)
●American Thyroid Association (ATA), the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and the ETA: A joint statement on controversies, consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer (2019)
●ETA: Guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer (2019)
●ETA: Guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults – The EU-TIRADS (2017)
●ETA: Guidelines regarding thyroid nodule molecular fine-needle aspiration cytology diagnostics (2017)
●ETA: Guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer (2013)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Interventional procedures guidance on high-intensity focused ultrasound for symptomatic benign thyroid nodules (2019)
●Management of thyroid cancer – United Kingdom national multidisciplinary guidelines (2016)
●NICE: Interventional procedures guidance on ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules (2016)
●British Thyroid Association (BTA): Guidelines for the management of thyroid cancer, 3rd edition (2014)
Australia-New Zealand
●Royal College of Pathologists of Australasia (RCPA): Thyroid cytology – Structured reporting protocol, 2nd edition (2019)
●Choosing Wisely Australia: Don't routinely order a thyroid ultrasound in patients with abnormal thyroid function tests if there is no palpable abnormality of the thyroid gland (2015)
Japan
●Japan Associations of Endocrine Surgeons (JAES): The revised clinical practice guidelines on the management of thyroid tumors – Core questions and recommendations for treatments of thyroid cancer (2020)
●Treatment of thyroid tumor – Japanese clinical guidelines (2013)
